Literature DB >> 1884742

Interspecies differences in the effect of pH on gallopamil protein binding to albumin and alpha 1-acid glycoprotein.

D R Rutledge1, M T Chong, M V Nelson.   

Abstract

There is little information about the factors which influence drug protein binding between species. We have therefore investigated the role of pH on the binding of gallopamil, a calcium channel antagonist known to exhibit pH-sensitive binding, among four species, human, baboon, bovine, and canine. We used pure protein solutions of alpha 1 acid glycoprotein (AAG) (60 mg.l-1), albumin (45 gm.l-1), and their combination and three values of pH, 7.0, 7.4, and 8.0. Gallopamil protein binding was determined over a concentration range of 2.0 x 10(-7) mol.l-1 to 2.1 x 10(-3) mol.l-1 using equilibrium dialysis. Gallopamil binding in all solutions was best described using a two binding site model in the combination solution and a one binding site model in the pure solutions. pH did not affect the number of identical binding sites. However, the influence of pH on gallopamil binding was species specific. Increasing the pH from 7.0 to 8.0 influenced binding affinity differently between species. There were directionally similar changes in unbound fraction at a gallopamil concentration of 2 x 10(-7) mol.l-1 as pH increased, although there were species differences in the degree of change. In protein solutions containing both AAG and albumin a reduction in pH from 7.4 to 7.0 resulted in species-specific increases in the unbound fraction. Increasing the pH from 7.4 to 8.0 again resulted in species-specific reductions in the unbound fraction of gallopamil. Similar changes were seen when pure AAG or albumin solutions were used, indicating species variance in both gallopamil protein binding and the effect of pH on binding.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884742     DOI: 10.1007/bf00279978

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  A structural transformation in bovine and human plasma albumins in alkaline solution as revealed by rotatory dispersion studies.

Authors:  W J LEONARD; K K VIJAI; J F FOSTER
Journal:  J Biol Chem       Date:  1963-06       Impact factor: 5.157

2.  The neutral transition and the environment of the sulfhydryl side chain of bovine plasma albumin.

Authors:  V R Zurawski; J F Foster
Journal:  Biochemistry       Date:  1974-08-13       Impact factor: 3.162

3.  Reversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotation.

Authors:  K Wallevik
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

4.  pK change of imidazole groups in bovine serum albumin due to the conformational change at neutral pH.

Authors:  B J Harmsen; S H De Bruin; L H Janssen; J F Rodrigues de Miranda; G A Van Os
Journal:  Biochemistry       Date:  1971-08-17       Impact factor: 3.162

5.  Pressure jump studies of proteins. I. Isomerization of bovine serum albumin at neutral pH.

Authors:  D E Goldsack; P M Waern
Journal:  Can J Biochem       Date:  1971-12

6.  Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis.

Authors:  J D Huang
Journal:  J Pharm Sci       Date:  1983-11       Impact factor: 3.534

7.  Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements.

Authors:  J Wilting; M M Weideman; A C Roomer; J H Perrin
Journal:  Biochim Biophys Acta       Date:  1979-08-28

8.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

9.  The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis.

Authors:  J Wilting; W F van der Giesen; L H Janssen; M M Weideman; M Otagiri; J H Perrin
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

10.  Gallopamil binding to human serum proteins.

Authors:  D R Rutledge; J A Pieper
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more
  1 in total

Review 1.  Gallopamil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in ischaemic heart disease.

Authors:  R N Brogden; P Benfield
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.